XML 65 R19.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Stockholders' Equity | 12 Months Ended
--- | ---
Oct. 31, 2019
Stockholders' Equity Note [Abstract] |
Stockholders' Equity |
10 | Stockholders' Equity
Stock Repurchase Program On December 3, 2015, the company's Board of Directors authorized the repurchase of 8,000,000 shares of the company's common stock in open-market or in privately negotiated transactions. On December 4, 2018, the company's Board of Directors authorized the repurchase of up to an additional 5,000,000 shares of common stock in open-market or in privately negotiated transactions under the authorized stock repurchase program. This authorized stock repurchase program has no expiration date but may be terminated by the Board at any time. During fiscal 2019, 2018, and 2017, the company paid $20.0 million, $160.4 million, and $159.4 million to repurchase an aggregate of 359,758 shares, 2,579,864 shares, and 2,710,837 shares, respectively, under the authorized stock repurchase program. As a result of the company's acquisition of CMW on April 1, 2019, the company curtailed the repurchase of shares of its common stock under the authorized stock repurchase program during the company's fiscal 2019 second, third, and fourth quarters. As of October 31, 2019, 7,042,256 shares remained authorized by the company's Board of Directors for repurchase. The authorized stock repurchase program does not include shares of the company's common stock surrendered by employees to satisfy minimum tax withholding obligations upon vesting of certain equity securities granted under the company's stock-based compensation plans. Treasury Shares As of October 31, 2019, the company had a total of 21,385,919 treasury shares at a cost of $1,374.0 million. As of October 31, 2018, the company had a total of 22,527,348 treasury shares at a cost of $1,448.4 million. Accumulated Other Comprehensive Loss Components of AOCL, net of tax, within the Consolidated Statements of Stockholders' Equity are as follows (in thousands):
As of October 31 |  | 2019 |  | 2018 |  | 2017
Foreign currency translation adjustments |  | $ | 31,025 |  |  | $ | 29,711 |  |  | $ | 21,303 |
Pension and post-retirement benefits |  | 4,861 |  |  | 561 |  |  | 2,012 |
Cash flow derivative instruments |  | (3,837 | ) |  | (6,335 | ) |  | 805 |
Total accumulated other comprehensive loss |  | $ | 32,049 |  |  | $ | 23,937 |  |  | $ | 24,120 |
The components and activity of AOCL are as follows (in thousands):
|  | Foreign Currency Translation Adjustments |  | Pension and Post-Retirement Benefits |  | Cash Flow Derivative Instruments |  | Total
Balance as of October 31, 2018 |  | $ | 29,711 |  |  | $ | 561 |  |  | $ | (6,335 | ) |  | $ | 23,937 |
Other comprehensive (income) loss before reclassifications |  | 1,314 |  |  | 4,300 |  |  | (4,048 | ) |  | 1,566 |
Amounts reclassified from AOCL |  | — |  |  | — |  |  | 6,546 |  |  | 6,546 |
Net current period other comprehensive loss |  | 1,314 |  |  | 4,300 |  |  | 2,498 |  |  | 8,112 |
Balance as of October 31, 2019 |  | $ | 31,025 |  |  | $ | 4,861 |  |  | $ | (3,837 | ) |  | $ | 32,049 |
|  | Foreign Currency Translation Adjustments |  | Pension and Post-Retirement Benefits |  | Cash Flow Derivative Instruments |  | Total
Balance as of October 31, 2017 |  | $ | 21,303 |  |  | $ | 2,012 |  |  | $ | 805 |  |  | $ | 24,120 |
Other comprehensive (income) loss before reclassifications |  | 8,408 |  |  | (1,035 | ) |  | (5,489 | ) |  | 1,884 |
Amounts reclassified from AOCL |  | — |  |  | — |  |  | (1,926 | ) |  | (1,926 | )
Net current period other comprehensive (income) loss |  | 8,408 |  |  | (1,035 | ) |  | (7,415 | ) |  | (42 | )
Reclassification due to the adoption of ASU 2018-02 |  | — |  |  | (416 | ) |  | 275 |  |  | (141 | )
Balance as of October 31, 2018 |  | $ | 29,711 |  |  | $ | 561 |  |  | $ | (6,335 | ) |  | $ | 23,937 |
For additional information on the components of AOCL associated with pension and post-retirement benefits refer to Note 15, Employee Retirement Plans. For additional information on the components reclassified from AOCL to the respective line items in net earnings for derivative instruments refer to Note 13, Financial Instruments.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration